Stay Safe. Stay Healthy.

 
India has been impacted severely by the second wave of COVID-19 infections since April 2021. Cases, hospital admissions, and fatality numbers were significantly higher this time (two to threefold) than in the first wave in 2020. The Indian healthcare industry faced new challenges such as inadequate oxygen supply and shortages of certain covid-related drugs in dealing with the pandemic. The vaccination program also could not be ramped up as needed across the population segments due to restricted availability and supply. With the severe second wave, lockdowns in civil society returned, and the focus within healthcare primarily shifted to management of the pandemic.

Similar to the previous wave, management of regular healthcare needs has suffered. OPD's, elective surgery, follow up of NCDs, etc. have all shown a sharp decline. Teleconsultation and telemedicine have received a fresh impetus with more consumers resorting to digital technology for management of their health needs. The need to seriously address the fundamental challenges of low healthcare spending, infrastructure, and resource scarcity in a planned manner is now even more clear and will need urgent Government attention and resources.

From an investment perspective, the healthcare industry in India continues to remain attractive. Returning economic growth, the large growing middle class, underserved populations, along with increased penetration of insurance and policy support will ensure attractive growth opportunities. COVID-19 has brought health security to the forefront of priorities for the industry, policy makers, and patients alike. We expect the sector to witness sustained growth in the medium- to long-term.
 
 Webinars
Indian Healthcare Today - New Opportunities and Access to Growth
India's rapidly evolving healthcare landscape has recently seen a series of policy reforms intended to stimulate the growth and development of this industry. Shifts in disease patterns and changes in the mindset of the population from curative to preventive healthcare have opened new opportunities for medical devices companies seeking to enter the Indian market.
India's MedTech and Digital Healthcare Market
India is becoming increasingly digital - and this is also true for healthcare. Increasing access to the internet is in turn giving the Indian population more access to digital healthcare. The market volume for digital health is growing continuously. In our webinar, medtech experts will explain the possibilities and opportunities opened up by this for Swiss medical technology companies.
2nd Annual Medical Device and Healthcare Supply Chain Asia Summit 2020
The COVID-19 pandemic has forced companies to reassess their approach towards work. Never has there been a time where the world has realized the importance of having a robust business continuity plan of action than as of now. As a BC program grows, there needs to be an evolution beyond the base level processes and procedures that the program manages.
 
 Articles
Good Distribution Practices for Pharmaceutical Products
Innovations driven by new science and technology have transformed human healthcare beyond recognition in the last 50 years. The healthcare...
 
Read More
National Digital Health Mission Harnessing Technology to Strengthen Healthcare in India
On India's 74th Independence Day, Hon'ble Prime Minister Narendra Modi announced a significant healthcare initiative for India...
 
Read More
Should COVID-19 vaccines be taxed?
Currently, the import of COVID-19 vaccines
(including bulk) falls under Chapter Heading 3002 is exigible to a Customs duty of approximately 16.50%, which includes basic Customs duty of...

 
Read More
Best practices not followed consistently across pharma supply chain due to lack of GDP guidelines
Currently, there are no mandated GDP norms issued by the Central Drug...
 
Read More
 
 Case Studies
 
 Quotes
Centre can cut GST rates on COVID-19 vaccines, critical supplies, say experts

Healthcare Budget 21-22: More needs to be done
 
 
 
Nexdigm (SKP)
Urmi Axis | 7th Floor | Famous Studio Lane |
Mahalaxmi | Mumbai | 400 011 | India
+91 22 6730 9000 | ThinkNext@nexdigm.com | www.nexdigm.com
USA | Canada | India | UAE | Japan | Hong Kong
© 2021 Nexdigm Private Limited. All rights reserved.